QUAZOMOTIDE
UNII WYT2ZC05X2

Substance Identification & Data

This profile provides standardized clinical and technical data for Quazomotide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) WYT2ZC05X2.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 935395-33-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

WYT2ZC05X2

CAS Registry Number

935395-33-8

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

QUAZOMOTIDE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C98H164N38O29S2

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

ARPXPQWBIFSBKF-AHEPKYPGSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C199097

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

121490081

Unique identification number in the NCBI database of chemical substances.

INN ID

12585

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

[C@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)O)CC(C)C)Cc1[nH]cnc1)(NC([C@@H](NC([C@H](CCCNC(N)=N)NC([C@H](C(C)C)NC([C@H](CC(C)C)NC([C@H](CCC(=O)O)NC([C@H](CC(=O)O)NC([C@H](CO)NC([C@@H](N)CCCNC(N)=N)=O)=O)=O)=O)=O)=O)=O)Cc2[nH]cnc2)=O)Cc3[nH]cnc3

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Quazomotide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.